Positive end-expiratory pressure (PEEP) applied during induction of anesthesia prevents atelectasis formation and increases the duration of nonhypoxic apnea in nonobese patients. PEEP also prevents atelectasis formation in morbidly obese patients. Because morbidly obese patients have difficult airway management more often and because arterial desaturation develops rapidly, we studied the clinical benefit of PEEP applied during anesthesia induction. Thirty morbidly obese patients were randomly allocated to one of two groups. In the PEEP group, patients breathed 100% O 2 through a continuous positive airway pressure device (10 cm H 2 O) for 5 min. After induction of anesthesia, they were mechanically ventilated with PEEP (10 cm H 2 O) for another 5 min until tracheal intubation. In the control group, the sequence was the same but without any continuous positive airway pressure or PEEP. We measured apnea duration until Spo 2 reached 90% and we performed arterial blood gases analyses just before apnea and at 92% Spo 2 . Nonhypoxic apnea duration was longer in the PEEP group compared with the control group (188 Ϯ 46 versus 127 Ϯ 43 s; P ϭ 0.002). Pao 2 was higher before apnea in the PEEP group (P ϭ 0.038). Application of positive airway pressure during induction of general anesthesia in morbidly obese patients increases nonhypoxic apnea duration by 50%. W hatever the clinical preoperative evaluation, unexpected difficult airway may occur. Therefore, administration of 100% O 2 has been a common practice for decades in order to increase the possible duration of nonhypoxic apnea, the so-called margin of safety. However, general anesthesia, even in the lung-healthy nonobese subject, causes an increase in intrapulmonary shunt (1) , which may impair oxygenation (2) . The magnitude of shunt is correlated with the formation of pulmonary atelectasis (3-5), which appears within minutes after induction of anesthesia (6) in 85%-90% of all patients (7) . Atelectasis is larger in morbidly obese patients (8) or when a high fraction of inspired oxygen (Fio 2 ) is used (9, 10) . Using low Fio 2 during administration of O 2 prevents atelectasis formation during induction of general anesthesia (10); however, this technique is not recommended because it reduces the duration of nonhypoxic apnea. Indeed, a recent study has shown that even Fio 2 as high as 0.8 may prevent atelectasis formation but at the cost of a reduction in the duration of nonhypoxic apnea of 90 s (11) .
We have previously shown that atelectasis formation can be effectively prevented by application of positive end-expiratory pressure (PEEP) during anesthesia induction despite the use of 100% O 2 in nonobese patients (12) . Moreover, the duration of nonhypoxic apnea is not only maintained but is increased from 8 to 10 min in nonobese patients with this technique (13) .
Morbidly obese patients are at increased risk of difficult airway management (14, 15) and, at the same time, their O 2 reserve is decreased because they will develop much more atelectasis during induction of general anesthesia than nonobese patients (8) . Consequently, the O 2 reserve in morbidly obese patients is diminished (16) . As we have shown that prevention of atelectasis formation by application of PEEP during induction is also effective in morbidly obese patients (17) , it may be that this technique will also increase the duration of nonhypoxic apnea in these patients.
The aim of this study was therefore to evaluate the clinical benefit, in terms of duration of nonhypoxic apnea, of PEEP applied during the induction period of general anesthesia in morbidly obese patients.
Methods
After local ethics committee approval and written informed consent, 30 ASA physical status II-III patients aged 18 -60 yr, with a body mass index (BMI) Ͼ35 kg/m 2 and scheduled for elective surgery were enrolled in this prospective, single-blinded study and randomly assigned to 1 of 2 groups. The estimation of the sample size was based on previous studies (16) . This size was calculated to detect a difference of 60 s of nonhypoxic apnea duration, accepting a type I error of 5% and type II error of 20%. Exclusion criteria were pregnancy, cardiac or pulmonary disease, and Spo 2 at ambient air Ͻ94%. Patients were also excluded if they had known carotid stenosis, pulmonary hypertension, or a history of neurological disorder. Sleep apnea syndrome was not considered to be an exclusion criterion.
No patients received premedication before surgery. In the operating room, patients were positioned with pillows or towels under their shoulders, with their head elevated and neck extended. Routine monitoring was initiated and the same pulse oximetry (type F-CU8-22-05; Datex-Engstrom, Helsinki, Finland) was used for all patients. General anesthesia was induced with propofol (effect site target: 4 g/mL), remifentanil (effect site target: 6 ng/mL), and cisatracurium (0.2 mg/kg). For maintenance, drugs were adjusted to obtain a clinically adequate depth of anesthesia and bispectral index between 40 and 50.
In the PEEP group, awake patients were administered 100% O 2 through a continuous positive airway pressure (CPAP) device (Dräger CF800; Drägerwerk, Lü beck, Germany) set at 10 cm H 2 O for 5 min. After induction of anesthesia, patients were mechanically ventilated with the pressure-controlled mode (type A-ELEC 00; Datex-Engstrom 5/5, Bromma, Sweden) (pressure-controlled ventilation at 14 cm H 2 O, PEEP 10 cm H 2 O, respiratory rate 8/') for another 5 min until tracheal intubation.
In the control group, patients had the same induction technique but without any PEEP or CPAP. They breathed spontaneously through the CPAP device without any positive pressure. After induction of general anesthesia, they were mechanically ventilated with the same settings but without any PEEP.
After tracheal intubation, no pressure was applied to the airway and correct placement of the endotracheal tube was confirmed by fibroscopy. The endotracheal tube was left open to air at atmospheric pressure and the patient was left apneic until Spo 2 reached 90%. Capnography was used to monitor involuntary breathing. Patients were then administered 100% O 2 and the recruitment maneuver (increasing airway pressure to 40 cm H 2 O for 15 s) was applied until Spo 2 reached initial values.
Nonhypoxic apnea was defined as the time needed to reach 90% Spo 2 from the end of mechanical ventilation. Arterial blood gases were measured twice: first, just before the beginning of the period of apnea and, second, when Spo 2 decreased to 92%.
Values were expressed as mean Ϯ sd. Paired and unpaired Student's t-test was used for comparisons within and between groups.
2 was used to compare discrete variables. The Pearson product-moment correlation coefficient was calculated to assess the relationship between the duration of nonhypoxic apnea and other variables. P value Ͻ 0.05 was considered significant. The statistical package used was JMP (version 5.01; SAS Institute, Cary, NC).
Results
Three patients of the PEEP group were excluded after randomization because of an Spo 2 at ambient air Ͻ94% in the operating room and, because of technical difficulties, only 11 arterial catheters could be inserted in each group (PEEP group: 12 patients, 11 patients with blood gases analysis; control group: 15 patients, 11 patients with blood gases analysis). The two study groups did not differ with respect to age, sex, BMI, smoking, and Spo 2 at ambient air (Table 1) . No patients had a difficult intubation, only one attempt was necessary, and the duration of intubation did not exceed 1 min in any patient.
Nonhypoxic apnea duration was significantly longer in the PEEP group than in the control group (188 Ϯ 46 versus 127 Ϯ 43 s; P ϭ 0.002) (Fig. 1) .
Just before apnea, Pao 2 was higher in the PEEP group than in the control group (376 Ϯ 145 versus 243 Ϯ 136 mm Hg, respectively; P ϭ 0.038) (Fig. 1) . No difference was seen for Paco 2 before apnea ( Table 2) . At 92% Spo 2 , there was no difference for Pao 2 or Paco 2 between the two groups ( Table 2) .
We found a negative correlation between BMI and nonhypoxic apnea duration in the control group (R 2 ϭ 0.51, P ϭ 0.003) but not in the PEEP group (R 2 ϭ 0.14, P ϭ 0.25) (Fig. 2) .
There was no correlation between BMI and Pao 2 before apnea in the control group (R 2 ϭ 0.21, P ϭ 0.16) or in the PEEP group (R 2 ϭ 0.18, P ϭ 0.20).
Discussion
The main finding of this study is that application of positive airway pressure (10 cm H 2 O) during induction of general anesthesia in morbidly obese patients increases nonhypoxic apnea duration by 50% or 1 minute. This is an important clinical benefit, because difficult airway management is frequently encountered in morbidly obese patients. Indeed, it has been shown that difficult tracheal intubation is more frequent in obese than in lean patients (15.5% versus 2.2%) (15) . The increase of the duration of nonhypoxic apnea that we have demonstrated may be explained by two mechanisms. First, PEEP decreases the amount of atelectasis as previously shown (17) , and this increases the functional residual capacity (FRC) which is the main oxygen store of the body (18) . Second, decreasing atelectasis also decreases intrapulmonary shunt (3,4) . Indeed, the higher Pao 2 seen in the PEEP group may reflect a lower level of intrapulmonary shunt. Therefore, increasing the oxygen store of the body and decreasing the intrapulmonary shunt may prolong the duration of nonhypoxic apnea and the margin of safety during anesthesia induction.
We have previously shown that application of PEEP of only 6 cm H 2 O in nonobese patients prolongs the duration of nonhypoxic apnea by Ͼ2 minutes (13) . In this study, the duration of nonhypoxic apnea in the control group, without any PEEP or CPAP, was 8 minutes. In our study, we found that in morbidly obese patients, when PEEP was applied, this duration of nonhypoxic apnea was only 3 min. This difference may be explained by the fact that even without any atelectasis, FRC is markedly decreased in morbidly obese patients compared with nonobese patients (19) . Therefore, the oxygen store of morbidly obese patients is less than in nonobese patients. Indeed, it has been shown that when FRC is decreased, as can be seen in women compared with men (20) , the duration of nonhypoxic apnea is also decreased (13) . Moreover, during apnea, the lungs are open to the atmosphere and atelectasis may arise very quickly in these circumstances when 100% O 2 has been used (21) . One of the mechanisms of atelectasis formation is compression (6) , particularly in the lower dorsal part of the lungs where the diaphragm compresses the lungs. In morbidly obese patients, the abdominal pressure is much higher than in nonobese patients (22, 23) and therefore this mechanism of compression is increased, hastening atelectasis formation and increasing intrapulmonary shunt during apnea. These two mechanisms may therefore explain the shorter duration of nonhypoxic apnea seen in morbidly obese compared with nonobese patients. Another finding of the present study is that there is a negative correlation between BMI and the nonhypoxic apnea duration when no CPAP or PEEP is applied (Fig. 2) . For the obese patients with the highest BMI, the time of desaturation may be Ͻ1 minute. However, when PEEP is applied, no such correlation is seen. Therefore, this technique may be useful even without difficult airway management.
One limitation of the study is that it is not possible to evaluate whether CPAP during the administration of O 2 is useful in the procedure or if PEEP during mechanical ventilation is sufficient for increasing the duration of nonhypoxic apnea. In a previous study, Cressey et al. (24) did not find that application of CPAP during administration of O 2 could prolong the time of desaturation in morbidly obese women. However, the administration of O 2 was limited to 3 minutes with only 7 cm H 2 O of CPAP and the induction was a rapid sequence with the use of succinylcholine without ventilation until tracheal intubation. This may explain why they did not find a beneficial effect of application of CPAP. It is possible that application of a higher level of CPAP might also be useful for rapid sequence induction with succinylcholine. Indeed, FRC is lower in supine morbidly obese patients and therefore during normal sleep they may develop atelectasis without high Fio 2 or general anesthesia. Therefore, application of CPAP may increase FRC and decrease the amount of atelectasis in awake patients but this remains to be demonstrated.
A potential risk of mechanical ventilation by mask with PEEP is to expose a sedated, paralyzed patient to insufflation of the stomach and, as a result, increase the risk of regurgitation and bronchoaspiration. This risk exists with an insufflation pressure Ͼ25 mm Hg, which can be obtained with manual ventilation (25, 26) . To avoid this complication, we used the pressure-controlled mode to ventilate the patients, which prevents the use of higher pressure. In addition, alarm limits of the ventilator can be set at 25 mm Hg, which will prevent the use of higher pressure via the facemask. Therefore, with this precaution, mechanical ventilation via facemask may even be safer than manual ventilation.
In conclusion, application of CPAP (10 cm H 2 O) for 5 minutes in conscious morbidly obese patients followed by 5 minutes of mechanical ventilation with PEEP (10 cm H 2 O) during anesthesia induction is safe, simple, and well tolerated (no patients refused to participate and all patients of the PEEP group tolerated CPAP for 5 min). This technique completely prevents atelectasis formation during anesthesia induction in morbidly obese patients (17) and increases nonhypoxic apnea duration by 50% (1 minute). Therefore, application of CPAP and PEEP throughout anesthesia induction might be applied in all morbidly obese patients, particularly when difficult airway management is anticipated or for extreme obesity. 
